Emergency Department and Inpatient Management of Headache in Adults
- PMID: 32189074
- DOI: 10.1007/s11910-020-01030-w
Emergency Department and Inpatient Management of Headache in Adults
Abstract
Purpose of review: This article reviews treatment options for patients presenting with headache in the emergency department (ED) and for inpatients, including red flags and status migrainosus (SM).
Recent findings: Most patients presenting with headache in the ED will have migraine, but red flags must be reviewed to rule out secondary headaches. SM refractory to home treatment is a common reason for ED presentation or inpatient admission, but high-quality treatment evidence is lacking. Common treatments include intravenous fluids, anti-dopaminergic agents with diphenhydramine, steroids, divalproex, nonsteroidal anti-inflammatory drugs, intravenous dihydroergotamine, and nerve blocks. Other therapies (e.g., ketamine and lidocaine) are used with limited or inconsistent evidence. There is evidence for inpatient behavioral management therapy. This article details red flags to review in the workup of headache presentation in the ED and provides a step-wise approach to ED and inpatient management. However, more studies are needed to better optimize care.
Keywords: Emergency; Headache; Inpatient; Migraine; Red flags; Status migrainosus.
Similar articles
-
Benign Headache Management in the Emergency Department.J Emerg Med. 2018 Apr;54(4):458-468. doi: 10.1016/j.jemermed.2017.12.023. Epub 2018 Feb 1. J Emerg Med. 2018. PMID: 29395690
-
Headaches in the emergency department -a survey of patients' characteristics, facts and needs.J Headache Pain. 2019 Nov 5;20(1):100. doi: 10.1186/s10194-019-1053-5. J Headache Pain. 2019. PMID: 31690261 Free PMC article.
-
Emergency Department and Inpatient Management of Status Migrainosus and Intractable Headache.Continuum (Minneap Minn). 2015 Aug;21(4 Headache):1004-17. doi: 10.1212/CON.0000000000000191. Continuum (Minneap Minn). 2015. PMID: 26252587 Review.
-
Pediatric Inpatient Headache Therapy: What is Available.Headache. 2015 Nov-Dec;55(10):1426-9. doi: 10.1111/head.12701. Epub 2015 Oct 31. Headache. 2015. PMID: 26517974 Review.
-
ED and Inpatient Management of Headache in Children and Adolescents.Curr Neurol Neurosci Rep. 2020 May 14;20(6):15. doi: 10.1007/s11910-020-01035-5. Curr Neurol Neurosci Rep. 2020. PMID: 32410204 Review.
Cited by
-
The NMDA receptor antagonists memantine and ketamine as anti-migraine agents.Naunyn Schmiedebergs Arch Pharmacol. 2023 Jul;396(7):1371-1398. doi: 10.1007/s00210-023-02444-2. Epub 2023 Mar 4. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36869904 Review.
-
Efficacy and safety of intranasal agents for the acute treatment of migraine: a systematic review and network meta-analysis.J Headache Pain. 2023 Sep 18;24(1):129. doi: 10.1186/s10194-023-01662-6. J Headache Pain. 2023. PMID: 37723470 Free PMC article.
-
Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine.Curr Pain Headache Rep. 2021 Dec 11;25(12):77. doi: 10.1007/s11916-021-00992-x. Curr Pain Headache Rep. 2021. PMID: 34894295 Free PMC article. Review.
-
Knowledge of Headache Red Flags among the General Population of Saudi Arabia: A Comprehensive Evaluation.Ann Afr Med. 2025 Apr 1;24(2):398-405. doi: 10.4103/aam.aam_254_24. Epub 2025 Mar 4. Ann Afr Med. 2025. PMID: 40041935 Free PMC article.
-
Primary Headache Approach in the Emergency Departments: A Systematic Scoping Review of Prospective Studies.Cureus. 2023 Mar 14;15(3):e36131. doi: 10.7759/cureus.36131. eCollection 2023 Mar. Cureus. 2023. PMID: 37065368 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials